Screener
BioRestorative Therapies BRTX Q4 2025 Annual earnings
Reported March 26, 2026 · Before market open
Revenue$20.0KMiss by $130.0K
EPS-$0.37In line
Revenue estimate$150.0K
EPS estimate-$0.37
Next report
Sep 22, 2026 (In 4 days)Revenue estimate$600.0K
EPS estimate-$2.00
Versus estimates
Revenue
FAQ
- When did BioRestorative Therapies report Q4 2025 earnings?
- BioRestorative Therapies (BRTX) reported Q4 2025 earnings on March 26, 2026 before market open.
- What were BioRestorative Therapies's Q4 2025 revenue and EPS?
- BioRestorative Therapies reported revenue of $20.0K and eps of $-0.37 for Q4 2025.
- Did BioRestorative Therapies beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $150.0K by $130.0K. EPS beat the consensus estimate of $-0.37 by $0.00.
- How did BioRestorative Therapies's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 53.8% from $43.3K a year earlier and eps declined 85.0% from $-0.20.
- Where can I find BioRestorative Therapies's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-012925) directly on SEC EDGAR. The filing index links above go to sec.gov.
